United States Pharmacopeia Company Profile

07:43 EST 14th February 2016 | BioPortfolio

The United States Pharmacopeia (USP) is the official public standards-setting authority for all prescription and over-the-counter medicines, dietary supplements, and other healthcare products manufactured and sold in the United States. USP sets standards for the quality of these products and works with healthcare providers to help them reach the standards. USP's standards are also recognized and used in more than 130 countries. These standards have been helping to ensure good pharmaceutical care for people throughout the world for more than 185 years.


12601 Twinbrook Parkway
United States of America


Phone: 1-800-227-8772

News Articles [1998 Associated News Articles listed on BioPortfolio]

Rapid methods update: revisions to a United States Pharmacopeia chapter

Pharmacopeia Requirements for Pure Steam and Final Rinse Verification of CIP

A white paper providing an overview of current pharmacopeia requirements.

New British Pharmacopeia website

The websites of the British Pharmacopeia, and (previously have been brought together into one integrated website. The new website is availab...

Kline: U.S. less aggressive on Rx-to-OTC switch than U.K., others

According to the latest Kline blog, the United States is not as aggressive in switching medicines from prescription-only to OTC as their counterparts overseas. "The United Kingdom is not the only...

MMWR QuickStats: Use of Selected Contraceptive Methods by Married Women of Childbearing Age in the United States, 2006-2008, Compared with Married Women in Selected Countries with Low Fertility Rates, 2000-2008

Among countries with low fertility (total fertility rates of ¡Ü2.1), a higher percentage of married women of childbearing age in the United States rely on female sterilization (24%) as their method ...

The State of Pharmaceutical Packaging: 1207 Revisions, Biologics Will Play Key Roles

In the fall of 2014, the United States Pharmacopeia (USP) released its proposed revisions to General Chapter 1207, Sterile Product Packaging—Integrity Evaluation. [1] The expanded chapter provides d...

United States Army to Procure LRAD(R) Equipment Under Existing United States Navy Contract

SAN DIEGO, CALIF., Dec. 15, 2015 (GLOBE NEWSWIRE) -- LRAD Corporation (NASDAQ: LRAD), the world's leading provider of Long Range Acoustic Devices® and advanced ONE VOICE™ Mass Notification Systems...

Options to Promote Competitive Generics Markets in the United States

This Viewpoint discusses the structure of the generic drug market in the United States and 3 different approaches that could stabilize it.

PubMed Articles [3040 Associated PubMed Articles listed on BioPortfolio]

The Evolution of Organized Plastic Surgery in the United States and Its Role as a Global Partner.

The medical environment in the United States is evolving rapidly and the stresses that plastic surgeons face are mounting. These changes and stresses are not unique to the United States but rather are...

Vital Signs: Melanoma Incidence and Mortality Trends and Projections - United States, 1982-2030.

Skin cancer is the most common form of cancer in the United States, and melanoma is responsible for the most skin cancer deaths with over 9,000 each year. An individual dying from melanoma loses an av...

Keratoplasty in the United States: A 10-Year Review from 2005 through 2014.

To report evolving indications and preferred techniques of corneal transplantation in the United States.

The Effect of State Policies on Organ Donation and Transplantation in the United States.

Shortages in transplantable solid organs remain a critical public health challenge in the United States. During the past 2 decades, all states have implemented policies to increase organ supply, altho...

Missed opportunities for prevention of mother-to-child transmission in the United States.

To describe system failures potentially contributing to perinatal HIV transmission in the state of Georgia, United States, between 2005 and 2012.

Clinical Trials [1075 Associated Clinical Trials listed on BioPortfolio]

Population-Based Modeling of Cholesterol Lowering in the United States

To evaluate the cost-effectiveness of cholesterol-lowering strategies in the United States population. The study used the Coronary Heart Disease (CHD) Policy Model, a state-transition com...

Imaging of Neuroendocrine Tumors With PET and Fluoro-18-DOPA (F-DOPA)

Imaging of neuroendocrine (NETs), such as carcinoids and pheochromocytomas (PHEOs), is suboptimal, limiting curative treatment. The investigators wanted to explore the use of PET and F-DOP...

Retrovirus Epidemiology Donor Study-II (REDS-II)

To conduct epidemiological, laboratory, and survey research on volunteer blood donors within the United States to ensure the safety and availability of the United States' blood supply.

Chagas Disease as an Undiagnosed Type of Cardiomyopathy in the United States

A detailed review was made of data pertinent to the occurrence of chronic Chagas disease in the United States.

An Observational Study of TNKase in Patients Enrolled in the National Registry of Myocardial Infarction 4 and 5 (POST)

The POST study comprised patients whose data were entered into the NRMI 4 and 5 databases. NRMI is a prospective, observational study of patients presenting with AMI in the United States. ...

Companies [2727 Associated Companies listed on BioPortfolio]

United States Pharmacopeia

The United States Pharmacopeia (USP) is the official public standards-setting authority for all prescription and over-the-counter medicines, dietary supplements, and other healthcare products manufact...

Pharmacopeia Incorporated

Pharmacopeia, Inc. is a leader in enabling technology and technology-based services that accelerate drug discovery and chemical development. Pharmacopeia's laboratory services segment - Pharmacopeia L...


ZBChem is A member of Zhejiang ZhongBao I/E Corp.,Ltd Since 1963.ZBChem is the biggest China Excipients supplier and also supply many kinds of Cosmetic raw materials, Intermediates and API’s Guaran...


Pharmacopeia is a biopharmaceutical company developing small molecule therapeutics to meet the needs of large patient populations suffering from significant unmet medical needs. With multiple internal...

Pharmacopeia Drug Discovery

Pharmacopeia is committed to discovering and developing novel therapeutics to address significant medical needs. The Company has a broad portfolio advancing toward clinical validation, both independen...

More Information about "United States Pharmacopeia" on BioPortfolio

We have published hundreds of United States Pharmacopeia news stories on BioPortfolio along with dozens of United States Pharmacopeia Clinical Trials and PubMed Articles about United States Pharmacopeia for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of United States Pharmacopeia Companies in our database. You can also find out about relevant United States Pharmacopeia Drugs and Medications on this site too.

Quick Search

Relevant Topic

Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Corporate Database Quicklinks

Searches Linking to this Company Record